A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
Clinical trial NCT06054893 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06054893
- Sponsor
- Biogen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-09-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.